TABLE 8.

Bioequivalence of the slope for the anti-HBs in-house assay compared to the AUSAB RIAa

Equivalence range lower specificationEquivalence range upper specificationEquivalence
0.502.00Yes
0.671.50Yes
0.801.25Yes
0.901.11Yes
  • a Shown are the results of Deming regression (ultrastructural model) with CVs of 11.86% for the RIA and the anti-HBS in-house assay. The regression represents a test of bioequivalence on the slope.